The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of ...

and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Market Capitalization Analysis: The company's market capitalization is ...

For fourth-quarter fiscal 2024, Abbott projects non-GAAP earnings ... sustain growth in the fourth quarter. The rapid and point-of-care diagnostics businesses are expected to have gained from ...

The new, streamlined app will be available via the Abbott-provided patient controller or personal iOS mobile devices and incorporates the award-winning NeuroSphere™ Virtual Clinic, giving people the ...